{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:36:24Z","timestamp":1782142584456,"version":"3.54.5"},"reference-count":19,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Patients suffering from chronic kidney disease (CKD) have a high risk of premature cardiovascular morbidity and mortality. It has been suggested that elevated homocysteine (Hcy) or disturbances in the transmethylation pathway may contribute to this high cardiovascular risk burden due to epigenetic mechanisms. The objective of this study was to explore the prognostic value of Hcy, S-adenosylhomocysteine (SAH) and S-adenosylmethionine (SAM) (one-carbon (C1)-metabolites) among patients with CKD. Methods: Plasma concentrations of Hcy, SAM and SAH were measured among 297 participants with CKD (KDIGO GFR category G2\u2013G5). The predefined endpoint was the occurrence of major cardiovascular events (MACE), defined as carotid, coronary and peripheral arterial revascularization, stroke, acute myocardial infarction, major amputation, cardiovascular death and all-cause mortality during a median (IQR) follow-up period of 4.0 [3.2; 4.3] years. Results: Among all participants, the median (IQR) of plasma Hcy, SAH, and SAM levels were 16.6 [13.5; 21.2] \u00b5mol\/L, 41.5 [26.6; 63.9] nmol\/L, 183.4 [151.1; 223.5] nmol\/L, respectively. Estimated glomerular filtration rate (eGFR) correlated more strongly with plasma SAH (r = \u22120.588) than with SAM (r = \u22120.497) and Hcy (r = \u22120.424). During the follow-up period, 55 participants experienced MACE. In a univariate Kaplan Meier analysis, all three C1-metabolites were significantly associated with the occurrence of the primary outcome. In a Cox-regression analysis, the association between Hcy and MACE was not significant after adjustment for age and sex (hazard ratio (HR) and 95% confidence intervals (95% CI) for the 3rd vs. 1st tertile = 1.804 (0.868\u20133.974)). Both SAH and SAM were not associated with MACE after adjustment for age, sex and additionally for renal function markers (SAH: HR 3rd vs. 1st tertile 1.645 95% (0.654\u20134.411); SAM: HR 3rd vs. 1st tertile 1.920 95% CI (0.764\u20135.138)). Conclusions: In people with CKD, plasma Hcy, SAH and SAM were not independent predictors of MACE after adjustment for age, sex and renal function. Disturbed renal function may explain elevated C1-metabolites and disturbed transmethylation, while this pathway is not likely to be an appropriate access point to modify the risk of cardiovascular events in CKD patients.<\/jats:p>","DOI":"10.3390\/nu17040626","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T08:05:42Z","timestamp":1739347542000},"page":"626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of Homocysteine, S-Adenosylhomocysteine and S-Adenosylmethionine with Cardiovascular Events in Chronic Kidney Disease"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-3659","authenticated-orcid":false,"given":"Insa E.","family":"Emrich","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Saarland University, 66421 Homburg, Germany"},{"name":"Department of Internal Medicine III, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-7029","authenticated-orcid":false,"given":"Rima","family":"Obeid","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saarland University, 66421 Homburg, Germany"},{"name":"Clinical Chemistry and Laboratory Medicine\/Central Laboratory, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Geisel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saarland University, 66421 Homburg, Germany"},{"name":"Clinical Chemistry and Laboratory Medicine\/Central Laboratory, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Fliser","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saarland University, 66421 Homburg, Germany"},{"name":"Department of Internal Medicine IV, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saarland University, 66421 Homburg, Germany"},{"name":"Department of Internal Medicine III, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saarland University, 66421 Homburg, Germany"},{"name":"AGAPLESION Markus Krankenhaus, 60431 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Zawada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1373\/49.8.1292","article-title":"Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease","volume":"49","author":"Castro","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1523-1755.2002.00144.x","article-title":"Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients","volume":"61","author":"Mallamaci","year":"2002","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/ndt\/gft042","article-title":"Clinical relevance of epigenetic dysregulation in chronic kidney disease-associated cardiovascular disease","volume":"28","author":"Zawada","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2009.117","article-title":"The kidney is the major site of S-adenosylhomocysteine disposal in humans","volume":"76","author":"Garibotto","year":"2009","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/CIRCRESAHA.121.320251","article-title":"Epigenetic Upregulation of H19 and AMPK Inhibition Concurrently Contribute to S-Adenosylhomocysteine Hydrolase Deficiency-Promoted Atherosclerotic Calcification","volume":"130","author":"Dai","year":"2022","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biocel.2015.06.015","article-title":"Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism","volume":"67","author":"Xiao","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3945\/ajcn.113.058727","article-title":"Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: A cohort study","volume":"98","author":"Xiao","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ndt\/gfy066","article-title":"Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?","volume":"34","author":"Emrich","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.jchromb.2009.09.039","article-title":"Simultaneous quantification of S-adenosyl methionine and S-adenosyl homocysteine in human plasma by stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry","volume":"877","author":"Kirsch","year":"2009","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006). Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med., 354, 1567\u20131577.","DOI":"10.1056\/NEJMoa060900"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1017\/S0007114509993552","article-title":"Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations","volume":"103","author":"Green","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2014.02.002","article-title":"S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population","volume":"234","author":"Zawada","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.metabol.2005.08.025","article-title":"Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children","volume":"55","author":"Jabs","year":"2006","journal-title":"Metabolism"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine","volume":"104","author":"Tsao","year":"2001","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/ajcn\/nqab210","article-title":"Association between plasma S-adenosylmethionine and risk of mortality in patients with coronary artery disease: A cohort study","volume":"114","author":"Liu","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000142725","article-title":"Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants","volume":"31","author":"Kielstein","year":"2008","journal-title":"Kidney Blood Press. Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/4\/626\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:30:06Z","timestamp":1760027406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/4\/626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["nu17040626"],"URL":"https:\/\/doi.org\/10.3390\/nu17040626","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}